ATS 2019 Virtual Final Program

BEHAVIORAL • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 D89 CONTROVERSIES IN PEDIATRIC PULMONOLOGY Assemblies on Pediatrics; Allergy, Immunology and Inflammation; Clinical Problems; Respiratory Structure and Function 1:30 p.m. - 3:30 p.m. OMNI DALLAS DOWNTOWN Dallas Ballroom A-C (Level 3) Target Audience Pediatric pulmonologists; allergists; emergency medicine practitioners; nurses; respiratory therapists; pharmacists Objectives At the conclusion of this session, the participant will be able to: • assess the medical and financial benefits of different methods of administration of inhaled medications; • assess the strength of the association between obesity and asthma, and determine the best strategies for their prevention and treatment; • asses the benefits and risks of one of the most commonly used drugs (diuretics) in prematurely born infants with acute and chronic lung disease. Despite the increasing emphasis on “Evidence Based Medicine” there are still many controversies surrounding the diagnosis and/or management of common conditions encountered in clinical practice. The session presents three controversies surrounding common conditions in pediatrics, pulmonology and neonatology. Discussions will cover obesity and asthma; methods of administration of inhaled bronchodilators and steroids (metered dose inhalers with valved holding chambers vs. nebulizers) and the benefits (and risks) of giving diuretics to prematurely born infants. Chairing: A.C. Koumbourlis, MD, MPH, ATSF, Washington, DC S.D.M. Dell, MD, ATSF, Toronto, Canada 1:30 Introduction A.C. Koumbourlis, MD, MPH, ATSF, Washington, DC 1:33 PRO: MDIs Should Be the Main/Only Method for the Administration of Bronchodilators J.A. Castro-Rodriguez, MD, PhD, Santiago, Chile 1:51 CON: MDIs Should Be the Main/Only Method for the Administration of Bronchodilators H.J. Farber, MD, MSPH, ATSF, Houston, TX 2:09 PRO: Obesity and Asthma - A Causal Relationship D. Rastogi, MBBS, MS, Bronx, NY 2:27 CON: Obesity and Asthma - A Causal Relationship C.S. Ulrik, PhD, Hvidovre, Denmark 2:45 PRO: Diuretics Should Not Be Given to Prematurely Born Infants Speaker To Be Announced 3:03 CON: Diuretics Should Not Be Given to Prematurely Born Infants R.H. Steinhorn, MD, Washington, DC 3:21 Questions and Discussion S.D.M. Dell, MD, ATSF, Toronto, Canada BEHAVIORAL • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 MOC Points Available: 2 D90 IMPROVING (LUNG) HEALTH IN PEOPLE LIVING WITH HIV Assemblies on Pulmonary Infections and Tuberculosis; Clinical Problems; Environmental, Occupational and Population Health; Pediatrics; Thoracic Oncology 1:30 p.m. - 3:30 p.m. KBHCCD Ballroom A Three (Level 2) Target Audience Clinicians, allied health professionals and academicians involved in the research and care of people living with HIV Objectives At the conclusion of this session, the participant will be able to: • advance clinician’s knowledge about pulmonary diseases in people living with HIV including screening, diagnosis, management, and prevention strategies; • facilitate and integrate newly acquired knowledge into clinical practice by personalizing and improving management of people living with HIV with different pulmonary conditions; • offer new strategies to manage the respiratory health of children, adolescents and adults living with HIV. Antiretroviral therapy has transformed the lives of many people living with HIV. Whilst acute opportunistic infections are less common, bacterial pneumonia and tuberculosis are still an issue, and non-communicable chronic respiratory disease such as COPD and lung cancer is an increasing concern. Smoking rates are exceedingly high and cessation is difficult in people living with HIV. Low and middle income countries face specific challenges in healthcare provision. This includes impact of the local environment (as a result of biomass exposure and high levels of pollution). This session will explore the challenge of maintaining long-term lung and general health in HIV, through the perspective of clinical and translational medicine in adults and children, epidemiology and behavioral science. Chairing: M.C.I. Lipman, MD, London, United Kingdom T.Y. Beiko, MD, Charleston, SC E. Attia, MD, MPH, Seattle, WA 1:30 Anti-Infective Interventions to Improve Lung Health in HIV K.M. Kunisaki, MD, MSCR, Minneapolis, MN 1:50 Managing Non-Communicable Respiratory Disease: COPD and ILD M.B. Drummond, MHS, MD, ATSF, Chapel Hill, NC 2:10 Prevention and Management of Lung Cancer M. Triplette, MD, MPH, Seattle, WA 2:30 Children and Adolescents with HIV: What Does the Future Hold? E. Attia, MD, MPH, Seattle, WA 2:50 HIV and Lung Disease in Low and Middle Income Countries C. North, MD, Boston, MA ATS 2019 • Dallas, TX 376 WEDNESDAY • MAY 22